Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
Open Access
- 18 September 2020
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 5 (51)
- https://doi.org/10.1126/sciimmunol.abd6197
Abstract
COVID-19 pathogenesis is associated with an exaggerated immune response. However, the specific cellular mediators and inflammatory components driving diverse clinical disease outcomes remain poorly understood. We undertook longitudinal immune profiling on both whole blood and peripheral blood mononuclear cells (PBMCs) of hospitalized patients during the peak of the COVID-19 pandemic in the UK. Here, we report key immune signatures present shortly after hospital admission that were associated with the severity of COVID-19. Immune signatures were related to shifts in neutrophil to T cell ratio, elevated serum IL-6, MCP-1 and IP-10, and most strikingly, modulation of CD14+ monocyte phenotype and function. Modified features of CD14+ monocytes included poor induction of the prostaglandin-producing enzyme, COX-2, as well as enhanced expression of the cell cycle marker Ki-67. Longitudinal analysis revealed reversion of some immune features back to the healthy median level in patients with a good eventual outcome. These findings identify previously unappreciated alterations in the innate immune compartment of COVID-19 patients and lend support to the idea that therapeutic strategies targeting release of myeloid cells from bone marrow should be considered in this disease. Moreover, they demonstrate that features of an exaggerated immune response are present early after hospital admission suggesting immune-modulating therapies would be most beneficial at early timepoints.Keywords
Funding Information
- Wellcome (202865/Z/16/Z)
- Biotechnology and Biological Sciences Research Council (BB/S01103X/1)
This publication has 48 references indexed in Scilit:
- Immunosuppressive Aspects of Analgesics and Sedatives Used in Mechanically Ventilated PatientsAnnals of Pharmacotherapy, 2013
- Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for PathogenesisThe Journal of Infectious Diseases, 2013
- Nonsteroidal Anti-Inflammatory Drugs Increase TNF Production in Rheumatoid Synovial Membrane Cultures and Whole BloodThe Journal of Immunology, 2010
- Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus InfectionClinical Infectious Diseases, 2010
- Host adaptive immunity deficiency in severe pandemic influenzaCritical Care, 2010
- Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding proteinThe International Journal of Biochemistry & Cell Biology, 2006
- Circulating CD10−/CD16low neutrophils provide a quantitative index of active bone marrow neutrophil releaseBritish Journal of Haematology, 2005
- Neutrophil Extracellular Traps Kill BacteriaScience, 2004
- CXC Chemokines IP-10 and Mig Expression and Direct Migration of Pulmonary CD8 + /CXCR3 + T Cells in the Lungs of Patients with HIV Infection and T-Cell AlveolitisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.The Journal of Experimental Medicine, 1978